CLBT · NASDAQ

Cellebrite DI Ltd.

Q: How do I get CLBT news from the API?

Call GET /v1/news?tickers=CLBT. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search articles since 2020 in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees articles since 2020.

$12.35 -0.09 (-0.72%)

Company overview

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle. The platform is used in various cases, including child exploitation, homicide, anti-terrorism, border control, sexual crimes, human trafficking, corporate security, intellectual property theft, and civil litigation. The company's Universal Forensic Extraction Device solution addresses challenges in accessing digital information, including device locks, encryption barriers, deleted and unknown content, and other obstacles that can prevent critical evidence from being uncovered.

Sector: Technology
Industry: Software - Infrastructure
Exchange: NASDAQ
Market cap: $3.1B
Employees: 1,167
Headquarters: Petah Tikva
Website: cellebrite.com
CEO: Thomas E. Hogan
Listed: November 6, 2020
P/E: 42.25
Dividend yield: 0.00%

Company financials

Revenue: $496M
Gross profit: $416M
Operating income: $63.3M
EBITDA: $118M
Net income: $71.9M
EPS: $0.29
Total assets: $952M
Total debt: $22.8M
Gross margin: 83.86%
Net margin: 14.48%
Earnings yield: 2.37%

Revenue segmentation

By product (FY 2025)

By region (FY 2025)

Showing FY 2025

Price chart

CLBT 1D NASDAQ O12.27H12.61L12.21C12.43+0.18 (+1.47%)Vol1.81M

News

Ticker	Type	Headline	Source	Published
CLBTCellebrite DI Ltd.	Press release	Cellebrite ernennt Rogerio Rizzi zum Executive Vice President für Corporate Strategy and Development	PR Newswire	Nov 5, 2:31:00 PM ET
CLBTCellebrite DI Ltd.	Press release	Cellebrite nomme Rogerio Rizzi vice-président exécutif de la stratégie et du développement de l'entreprise	PR Newswire	Nov 5, 11:51:00 AM ET
CLBTCellebrite DI Ltd.	Press release	Cellebrite Appoints Rogerio Rizzi Executive Vice President of Corporate Strategy and Development	PR Newswire	Nov 5, 8:30:17 AM ET
CLBTCellebrite DI Ltd.	Press release	Cellebrite nombra a Rogerio Rizzi vicepresidente ejecutivo de Estrategia y Desarrollo Corporativo	PR Newswire	Nov 5, 8:30:00 AM ET
CLBTCellebrite DI Ltd.	Legal	INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellebrite DI Ltd. - CLBT	ACCESS Newswire	Oct 25, 10:00:00 AM ET
CLBTCellebrite DI Ltd.	Legal	INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellebrite DI Ltd. - CLBT	PRNewsWire	Oct 22, 10:00:00 AM ET
CLBTCellebrite DI Ltd.	Press release	Genesis Momentum treibt das Herbst-Release von Cellebrite voran: Mehr Beweismaterial, tiefere Einblicke und umfassenderer Zugriff für Ermittlungszwecke Ermittler berichten von deutlichen Fortschritten bei der Aufdeckung von Beweismaterial d.	PR Newswire	Oct 21, 9:23:00 AM ET
CLBTCellebrite DI Ltd.	Press release	Genesis Momentum propulse la version automnale de Cellebrite : plus de preuves, une compréhension plus approfondie, un accès plus large pour les enquêtes Cellebrite (Nasdaq : CLBT), un leader mondial des solutions d'enquête et de renseignem.	PR Newswire	Oct 21, 9:21:00 AM ET
CLBTCellebrite DI Ltd.	Press release	El impulso de Genesis impulsa el lanzamiento de otoño de Cellebrite Cellebrite (Nasdaq: CLBT), líder mundial en soluciones de investigación digital e inteligencia basadas en inteligencia artificial para los sectores...	PR Newswire	Oct 21, 8:30:00 AM ET
CLBTCellebrite DI Ltd.	Press release	Genesis Momentum Powers Cellebrite's Autumn Release: More Evidence, Deeper Insight, Broader Access for Investigations Cellebrite (Nasdaq: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public a.	PR Newswire	Oct 21, 8:30:00 AM ET
CLBTCellebrite DI Ltd.	Press release	Cellebrite publiera ses résultats financiers du troisième trimestre 2026 le 12 novembre 2026 Cellebrite DI Ltd. (NASDAQ : CLBT), leader mondial des solutions numériques d'investigation et de renseignement basées sur l'IA pour les secteurs.…	PR Newswire	Oct 20, 12:40:00 PM ET
CLBTCellebrite DI Ltd.	Press release	Cellebrite presentará sus resultados financieros del tercer trimestre de 2026 el 12 de noviembre de 2026 Cellebrite DI Ltd.	PR Newswire	Oct 20, 9:48:00 AM ET
CLBTCellebrite DI Ltd.	Press release	Cellebrite wird die Finanzergebnisse für das dritte Quartal 2026 am 12. November 2026 veröffentlichen. Cellebrite DI Ltd.	PR Newswire	Oct 20, 9:21:00 AM ET
CLBTCellebrite DI Ltd.	Press release	Cellebrite to Report Third-Quarter 2026 Financial Results on November 12, 2026 Cellebrite DI Ltd. (NASDAQ: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, ...	PR Newswire	Oct 20, 8:30:00 AM ET
CLBTCellebrite DI Ltd.	Legal	INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellebrite DI Ltd. - CLBT	ACCESS Newswire	Oct 19, 5:37:00 PM ET
CLBTCellebrite DI Ltd.	Legal	INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellebrite DI Ltd. - CLBT	ACCESS Newswire	Oct 17, 10:00:00 AM ET
CLBTCellebrite DI Ltd.	Legal	INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellebrite DI Ltd. - CLBT Pomerantz LLP is investigating claims on behalf of investors Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).	PR Newswire	Oct 15, 10:00:00 AM ET
CLBTCellebrite DI Ltd.	Legal	INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellebrite DI Ltd. – CLBT	GlobeNewswire	Oct 13, 5:11:19 PM ET
CLBTCellebrite DI Ltd.	Legal	INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellebrite DI Ltd. - CLBT	ACCESS Newswire	Oct 11, 10:00:00 AM ET
CLBTCellebrite DI Ltd.	Legal	Bronstein, Gewirtz & Grossman, LLC Encourages Bronstein, Gewirtz & Grossman, LLC (CLBT) Investors to Inquire about Securities Investigation	ACCESS Newswire	Oct 9, 1:00:00 PM ET

FAQ

Questions about Cellebrite DI Ltd.

What does Cellebrite DI Ltd. do?

What is CLBT's market cap?

Cellebrite DI Ltd. (CLBT) is a listed stock with a live quote. The latest market cap on this page is $3.1B.

Where is Cellebrite DI Ltd. headquartered?

Cellebrite DI Ltd. is headquartered in Petah Tikva.

How do I get CLBT news from the API?

Call GET /v1/news?tickers=CLBT. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search articles since 2020 in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees articles since 2020.

How far back does CLBT news go?

Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for CLBT, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees articles since 2020 as headlines are ingested. A Free API key returns the last year. Pro keys search articles since 2020.

Is the CLBT price on this page from the API?

The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.

Can I use the Pro plan commercially?

No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 250 REST requests a day, 1 WebSocket connection, 5 requests per second, and 2,500 WebSocket messages a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.

Start 7-day free trial Read the docs